Is Wegovy Available in Wales on the NHS or Privately?

Step 1: Understand how Welsh NHS weight management services are commissioned

The NHS in Wales is organised through seven regional health boards, each responsible for commissioning its own services. Weight management (including access to medicines like Wegovy) falls under this devolved structure, which means what is available in Cardiff differs from what is available in Wrexham or Swansea.

Wegovy is recommended by NICE for weight management under NICE technology appraisal TA875, but NICE guidance applies directly to NHS England. In Wales, equivalent decisions are made by the All Wales Medicines Strategy Group (AWMSG). Welsh health boards monitor AWMSG and NICE outputs, but adoption timelines are set locally. In practice, NHS access to Wegovy in Wales is currently available only through specialist weight management services (tier 3 and above) and waiting lists at many centres run to many months.

If you are already under a specialist service, it is worth asking your clinical team directly whether Wegovy is on the formulary for your health board. That question takes under a minute, and the answer tells you exactly where you stand.

NHS England's guidance on weight management injections sets out the wraparound diet and activity support that accompanies treatment in a specialist setting, Welsh services follow a broadly similar model, though the pathway varies by health board.

Step 2: Know what private access looks like for people living in Wales

For many people in Wales, the NHS route means a long wait or not yet meeting the referral threshold. Private prescription is the alternative, and it is legal, regulated and increasingly common.

Any regulated online pharmacy operating in the UK can legally prescribe and dispense Wegovy to someone in Wales, provided a prescriber has assessed them and found them clinically suitable. Geography does not restrict which registered pharmacy you use. You can read more about how the broader availability picture has developed on our UK availability overview.

The private licensed eligibility criteria follow the medicine's UK marketing authorisation: adults with a BMI of 30 or above, or 27–29.9 alongside a qualifying condition such as high cholesterol, hypertension, obstructive sleep apnoea or pre-diabetes. A lower BMI threshold of 2.5 kg/m² applies for some ethnic backgrounds under UK clinical guidance. BMI alone does not determine suitability, a prescriber looks at the full picture, including other medicines, medical history and current health conditions.

If you want to explore what treatment through a clinically supervised Wegovy programme involves, our treatment overview covers the process from consultation to delivery.

Step 3: Check whether the pharmacy you choose is properly registered

Wherever you access Wegovy, the pharmacy dispensing it must be registered with the General Pharmaceutical Council. It takes about thirty seconds to confirm: the GPhC holds a public register at pharmacyregulation.org/registers where you can search by pharmacy name or registration number. If a seller is not listed there, do not proceed. The MHRA has documented cases of counterfeit weight-loss pens sold through social media and unverified websites, some containing substances that caused serious harm. Reporting a suspect seller via the MHRA Yellow Card scheme is how the regulator tracks these patterns.

A legitimate pharmacy will always require a prescriber's assessment before dispensing. If a site offers Wegovy without that step, that is the clearest possible warning sign.

For a fuller picture of how availability has changed recently (including the newer 7.2mg pen option) our current availability page keeps that detail updated.

What differs for Wales compared with Scotland or England

The question comes up often, so it is worth being direct. Scotland has its own access framework through the Scottish Medicines Consortium, and NHS Scotland's phased approach to weight management medicines differs from the NHS England rollout, we have a separate page covering Scotland specifically. England, meanwhile, has moved further down a phased commissioning path under NICE TA875 and the NHS England weight management programme.

Wales sits somewhere in between: AWMSG has considered semaglutide for weight management, and Welsh health boards are at varying stages of implementation. For most people in Wales right now, NHS access means a specialist referral, a wait, and participation in a structured support programme once a place becomes available.

If you are exploring your options and want to understand whether you might be clinically suitable for treatment today, our prescribers carry out a thorough same-day review, a real clinician reads your answers, not a piece of software. You can find out more about how semaglutide works before deciding whether to take the next step, or browse our treatment options more broadly. If you would also like to check which clinics and services are accessible to you, our guide to finding Wegovy available near me covers both NHS and private options by location. When you are ready, speaking to our prescribers is the natural starting point.